Abstract:The human gut microbiota is a complex microbial community with critical functions for the host, including the transformation of various chemicals. While effects on microorganisms has been evaluated using single-species models, their functional effects within more complex microbial communities remain unclear. In this study, we investigated the response of a simplified human gut microbiota model (SIHUMIx) cultivated in an in vitro bioreactor system in combination with 96 deep-well plates after exposure to 90 different xenobiotics, comprising 54 plant protection products and 36 food additives and dyes, at environmentally relevant concentrations. We employed metaproteomics and metabolomics to evaluate changes in bacterial abundances, the production of Short Chain Fatty Acids (SCFAs), and the regulation of metabolic pathways. Our findings unveiled significant changes induced by 23 out of 54 plant protection products and 28 out of 36 food additives across all three categories assessed. Notable highlights include azoxystrobin, fluroxypyr, and ethoxyquin causing a substantial reduction (log 2 FC < −0.5) in the concentrations of the primary SCFAs: acetate, butyrate, and propionate. Several food additives had significant effects on the relative abundances of bacterial species; for example, acid orange 7 and saccharin led to a 75% decrease in Clostridium butyricum , with saccharin causing an additional 2.5-fold increase in E. coli compared to the control. Furthermore, both groups exhibited up- and down-regulation of various pathways, including those related to the metabolism of amino acids such as histidine, valine, leucine, and isoleucine, as well as bacterial secretion systems and energy pathways like starch, sucrose, butanoate, and pyruvate metabolism. This research introduces an efficient in vitro technique that enables high-throughput screening of the structure and function of a simplified and well-defined human gut microbiota model against 90 chemicals using metaproteomics and metabolomics. We believe this approach will be instrumental in characterizing chemical-microbiota interactions especially important for regulatory chemical risk assessments.

A high-throughput screening platform for discovering bacterial species and small molecules that modify animal physiology

Phenotypic high-throughput screening identifies modulators of gut microbial choline metabolism

The footprints of gut microbial-mammalian co-metabolism.

A based system for high-throughput functional phenotyping of human gut microbiota

A Caenorhabditis elegans based system for high-throughput functional phenotyping of human gut microbiota

High-throughput screening of the effects of 90 xenobiotics on the simplified human gut microbiota model (SIHUMIx): a metaproteomic and metabolomic study

The effect of different combinations of antibiotic cocktails on mice and selection of animal models for further microbiota research

A metabolomics pipeline for the mechanistic interrogation of the gut microbiome

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites

Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance

High-throughput screening of caterpillars as a platform to study host–microbe interactions and enteric immunity

A Top-Down Systems Biology View of Microbiome-Mammalian Metabolic Interactions in A Mouse Model

Regulation of MicroRNA Machinery and Development by Interspecies S-Nitrosylation

Baat Gene Knockout Alters Post-Natal Development, the Gut Microbiome, and Reveals Unusual Bile Acids in Mice

Microbial bile salt hydrolase activity influences gene expression profiles and gastrointestinal maturation in infant mice

A sphingolipid-mTORC1 nutrient-sensing pathway regulates animal development by an intestinal peroxisome relocation-based gut-brain crosstalk

Prevention of antibiotic-associated metabolic syndrome in mice by intestinal alkaline phosphatase

Gut-derived metabolites influence neurodevelopmental gene expression and Wnt signaling events in a germ-free zebrafish model

Gut in tube – continuous measurement of metabolic crosstalk between gut microbiota and colonocytes by NMR imaging

Personalized Mapping of Drug Metabolism by the Human Gut Microbiome

Niche-specific metabolic phenotypes can be used to identify antimicrobial targets in pathogens